Pages that link to "Q33517628"
Jump to navigation
Jump to search
The following pages link to Therapeutic and adverse effects of a non-steroidal glucocorticoid receptor ligand in a mouse model of multiple sclerosis (Q33517628):
Displaying 26 items.
- Discovery of Compound A--a selective activator of the glucocorticoid receptor with anti-inflammatory and anti-cancer activity (Q26782111) (← links)
- Selective glucocorticoid receptor modulation: New directions with non-steroidal scaffolds (Q26825916) (← links)
- Selective non-steroidal glucocorticoid receptor agonists attenuate inflammation but do not impair intestinal epithelial cell restitution in vitro (Q28479065) (← links)
- Compound A, a dissociated glucocorticoid receptor modulator, inhibits T-bet (Th1) and induces GATA-3 (Th2) activity in immune cells (Q28482191) (← links)
- Differential cytokine profiles upon comparing selective versus classic glucocorticoid receptor modulation in human peripheral blood mononuclear cells and inferior turbinate tissue (Q28546223) (← links)
- Evaluation of the selective glucocorticoid receptor agonist compound A for ototoxic effects (Q30382813) (← links)
- Noise trauma and systemic application of the selective glucocorticoid receptor modulator compound A. (Q30383830) (← links)
- Influence of short-term glucocorticoid therapy on regulatory T cells in vivo (Q34017908) (← links)
- Preventive treatment with methylprednisolone paradoxically exacerbates experimental autoimmune encephalomyelitis (Q36454930) (← links)
- Effect of the plant derivative Compound A on the production of corticosteroid-resistant chemokines in airway smooth muscle cells. (Q36549178) (← links)
- Chemokine-mediated redirection of T cells constitutes a critical mechanism of glucocorticoid therapy in autoimmune CNS responses (Q37091531) (← links)
- GR-independent down-modulation on GM-CSF bone marrow-derived dendritic cells by the selective glucocorticoid receptor modulator Compound A. (Q37421622) (← links)
- Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1. (Q37470723) (← links)
- Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. (Q38417153) (← links)
- Novel Drug Delivery Systems Tailored for Improved Administration of Glucocorticoids (Q38637805) (← links)
- Compound A influences gene regulation of the Dexamethasone-activated glucocorticoid receptor by alternative cofactor recruitment (Q38642503) (← links)
- Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential (Q38735389) (← links)
- Combination of a selective activator of the glucocorticoid receptor Compound A with a proteasome inhibitor as a novel strategy for chemotherapy of hematologic malignancies. (Q39223255) (← links)
- Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice. (Q42030632) (← links)
- Selective glucocorticoid receptor modulation maintains bone mineral density in mice (Q43751384) (← links)
- Deletion of the Mineralocorticoid Receptor in Myeloid Cells Attenuates Central Nervous System Autoimmunity (Q47120039) (← links)
- Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism. (Q55066536) (← links)
- Effect of combining glucocorticoids with Compound A on glucocorticoid receptor responsiveness in lymphoid malignancies. (Q55281041) (← links)
- Disease and treatment associated acquired glucocorticoid resistance (Q57818892) (← links)
- GR Dimerization and the Impact of GR Dimerization on GR Protein Stability and Half-Life (Q92405217) (← links)
- Glucocorticoid Therapy of Multiple Sclerosis Patients Induces Anti-inflammatory Polarization and Increased Chemotaxis of Monocytes (Q92700344) (← links)